Glibenclamide Enhances the Therapeutic Benefits of Early Hypothermia after Severe Stroke in Rats

Glibenclamide (GBC) is an antidiabetic drug that is in a class of medications known as sulfonylureas, which play critical roles in attenuating brain edema and reducing mortality in ischemic stroke patients. Therapeutic hypothermia (TH) is another robust neuroprotectant that prevents brain swelling a...

全面介紹

Na minha lista:
書目詳細資料
發表在:Aging Dis
Main Authors: Zhu, Shuzhen, Gao, Xiaoya, Huang, Kaibin, Gu, Yong, Hu, Yafang, Wu, Yongming, Ji, Zhong, Wang, Qing, Pan, Suyue
格式: Artigo
語言:Inglês
出版: JKL International LLC 2018
主題:
Orginal Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6065285/
https://ncbi.nlm.nih.gov/pubmed/30090656
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14336/AD.2017.0927
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍